Cambium

United States - El Segundo, Los Angeles, CA

• 06/12/2023
• Series A
• $19,000,000

Cambium works at the interface of biotech and materials science to build next-generation defense products. We integrate computational chemistry, product design, and advanced manufacturing methods to solve difficult challenges like hardening critical assets against laser attack, protecting payloads during hypersonic flight, and streamlining the defense product manufacturing supply chain. Our people come from places like SpaceX, Anduril, Scaled Composites, Lockheed Martin Skunkworks, and US DoD Research Labs.

Related People

Simon WaddingtonCo Founder

United States - San Francisco Bay Area

Building entrepreneurial businesses leveraging biotechnology, materials and tech. Held executive positions in both private and public companies.

LinkedIn https://www.linkedin.com/in/simon-waddington/